On 29 February, a woman in Delft was diagnosed with the novel coronavirus (COVID-19) in the Netherlands. The woman had been in Lombardy, in Northern Italy, last week.

A patient in the Netherlands was diagnosed with the novel coronavirus (COVID-19). Tests confirmed this today.

On Tuesday evening 25 February, it was announced that a German man was tested positive for COVID-19. He would have been in the Netherlands last week.

Active Lyme disease of the central nervous system cannot be detected with an ELISpot test.

The societal costs of Lyme disease have been determined for the Netherlands for the first time. The disease appears to cost nearly EUR 20 million each year.

Lyme disease can cause a variety of complaints in patients. Laboratory tests for the disease can support medical practitioners in making a diagnosis but are not necessarily conclusive.

The Netherlands is the first country where the burden of disease due to Lyme disease has been determined.